CYP2D6 phenotypes among Malays in Malaysia
- 1 October 2000
- journal article
- Published by Hindawi Limited in Journal of Clinical Pharmacy & Therapeutics
- Vol. 25 (5) , 379-383
- https://doi.org/10.1046/j.1365-2710.2000.00304.x
Abstract
Although they originated from China, Malays have undergone a lot of intermarriages. A study suggested that CYP2D6 poor metabolism (PM) phenotype was more common in Malays compared to Chinese. CYP2D6 is highly polymorphic and is involved in the metabolism of many drugs and has been implicated in some environmentally-induced diseases. It is therefore useful to further study this polymorphism in Malays.To study debrisoquine metabolism phenotypes in healthy Malay volunteers.We administered debrisoquine to 51 Malays and used HPLC to measure urinary debrisoquine and 4-hydroxy debrisoquine to calculate debrisoquine metabolic ratios (MR).Debrisoquine MR varied widely and with probit analysis we were able to identify population subsets. Although the frequency distribution for the MR showed a right shift, the shift was less than that reported for the Chinese population. We also found 2 poor metabolizers and one ultra rapid metaboliser in the population.The genetic polymorphism of debrisoquine in Malays differs from that in the Chinese. Both their PM prevalence and their MR distribution suggest that they are intermediate between Europeans and Chinese in relation to this polymorphism. Studies to compare CYP2D6 genotypes between them and related races would be useful to further define these differences.Keywords
This publication has 12 references indexed in Scilit:
- Genetic polymorphism of CYP2D6 in a Keralite (South India) populationBritish Journal of Clinical Pharmacology, 2000
- Polymorphism of dextromethorphan oxidation in South Indian subjectsClinical Pharmacology & Therapeutics, 1999
- Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolutionPharmacogenetics, 1997
- Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean populationPharmacogenetics, 1996
- Evidence for the polymorphic oxidation of debrisoquine and proguanil in a Khmer (Cambodian) population.British Journal of Clinical Pharmacology, 1995
- Frequency of human CYP2D6 mutant alleles in a normal Chinese population.British Journal of Clinical Pharmacology, 1994
- Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoinClinical Pharmacology & Therapeutics, 1992
- Evidence for the polymorphic oxidation of debrisoquine in the Thai population.British Journal of Clinical Pharmacology, 1990
- OXIDATION PHENOTYPING IN CHINESE AND MALAY POPULATIONSClinical and Experimental Pharmacology and Physiology, 1988
- The polymorphic 4-hydroxylation of debrisoquine in a Saudi arab populationXenobiotica, 1980